Publication Name	World Journal of Clinical Cases
Manuscript ID	80540
Country	China

Received	2022-10-02 06:26
Peer-Review Started	2022-10-02 06:27
First Decision by Editorial Office Director	2022-10-21 01:27
Return for Revision	2022-10-21 01:27
Revised	2022-11-02 06:38
Publication Fee Transferred
Second Decision by Editor	2022-11-23 03:13
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2022-11-23 10:30
Articles in Press	2022-11-23 10:30
Edit the Manuscript by Language Editor	2022-11-20 12:56
Typeset the Manuscript	2022-12-02 05:59
Publish the Manuscript Online	2022-12-14 07:20

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Case Report
Article Title	Multidisciplinary treatment of a patient with severe immune checkpoint inhibitor-induced colitis: A case report
Manuscript Source	Unsolicited Manuscript
All Author List	Lu Lu, Li Sha, Yu Feng and Liang Yan
ORCID	Author(s) ORCID Number Liang Yan http://orcid.org/0000-0002-3989-414X
Funding Agency and Grant Number	Funding Agency Grant Number Shanghai Municipal Health Commission, Shanghai Muricipal Administrator of Traditional Chinese Medicine NO. ZY (2021-2023)-0201-02
Corresponding Author	Liang Yan, PhD, Associate Chief Physician, Department of General Surgery, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, No. 185 Pu'an Road, Huangpu District, Shanghai 200021, China. yanliang0831@163.com
Key Words	Immune checkpoint inhibitor; Colitis; Programmed cell death ligand 1; Infliximab; Laparoscopic surgery; Case report
Core Tip	Immune checkpoint inhibitors (ICIs) sometimes lead to diarrhea and colitis, which are routinely treated with immunosuppressive therapy. For ICI-related colitis with ineffective medical treatment, timely surgical intervention could prevent the death of patients.
Publish Date	2022-12-14 07:20
Citation	Lu L, Sha L, Feng Y, Yan L. Multidisciplinary treatment of a patient with severe immune checkpoint inhibitor-induced colitis: A case report. World J Clin Cases 2022; 10(35): 13108-13114
URL	https://www.wjgnet.com/2307-8960/full/v10/i35/13108.htm
DOI	https://dx.doi.org/10.12998/wjcc.v10.i35.13108

Full Article (PDF)	WJCC-10-13108.pdf
Full Article (Word)	WJCC-10-13108.docx
Manuscript File	80540_Auto_Edited-YLC-Wang TQ-JLW.docx
Answering Reviewers	80540-Answering reviewers.pdf
Audio Core Tip	80540-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	80540-Conflict-of-interest statement.pdf
Copyright License Agreement	80540-Copyright license agreement.pdf
Signed Consent for Treatment Form(s) or Document(s)	80540-Informed consent statement.pdf
Non-Native Speakers of English Editing Certificate	80540-Language certificate.pdf
Peer-review Report	80540-Peer-review(s).pdf
Scientific Misconduct Check	80540-Bing-Chen YL-2.png
Scientific Editor Work List	80540-Scientific editor work list.pdf
CrossCheck Report	80540-CrossCheck report.pdf